HomeCCEL • NYSEAMERICAN
Cryo-Cell International Inc
$7.06
Jan 13, 12:09:38 AM GMT-5 · USD · NYSEAMERICAN · Disclaimer
StockUS listed securityUS headquartered
Previous close
$7.40
Day range
$7.05 - $7.56
Year range
$4.47 - $9.50
Market cap
56.92M USD
Avg Volume
14.10K
P/E ratio
-
Dividend yield
14.16%
Market news
Financials
Income Statement
Revenue
Net income
(USD)Aug 2024Y/Y change
Revenue
8.07M2.50%
Operating expense
4.54M2.44%
Net income
1.05M54.53%
Net profit margin
13.0450.75%
Earnings per share
0.1457.14%
EBITDA
1.65M1.64%
Effective tax rate
23.78%
Total assets
Total liabilities
(USD)Aug 2024Y/Y change
Cash and short-term investments
2.13M67.97%
Total assets
62.93M-9.83%
Total liabilities
72.49M3.84%
Total equity
-9.56M
Shares outstanding
8.06M
Price to book
-6.22
Return on assets
5.59%
Return on capital
136.21%
Net change in cash
(USD)Aug 2024Y/Y change
Net income
1.05M54.53%
Cash from operations
2.44M25.48%
Cash from investing
-665.60K80.34%
Cash from financing
-2.04M-326.08%
Net change in cash
-271.76K49.67%
Free cash flow
683.20K116.82%
About
Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL. Wikipedia
Founded
1989
Employees
85
Search
Clear search
Close search
Google apps
Main menu